Robert M. Califf

Professor of Medicine
Donald F. Fortin, M.D. Professor of Cardiology, in the School of Medicine
Member of the Duke Clinical Research Institute
Campus mail 100 Trent Drive, Suite401, Davison Building, Durham, NC 27710
Phone (919) 668-9222
Email address robert.califf@duke.edu

Robert Califf, MD MACC, is the Donald F. Fortin, MD, Professor of Cardiology. He is also Professor of Medicine in the Division of Cardiology and remains a practicing cardiologist. Dr. Califf was the Commissioner of Food and Drugs in 2016-2017 and  Deputy Commissioner for Medical Products and Tobacco from February 2015 until his appointment as Commissioner in February 2016. Prior to joining the FDA, Dr. Califf was a professor of medicine and vice chancellor for clinical and translational research at Duke University. He also served as director of the Duke Translational Medicine Institute and founding director of the Duke Clinical Research Institute. A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, healthcare quality, and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,200 publications in the peer-reviewed literature.

Dr. Califf is a Member of the National Academy of Medicine (formerly known as the Institute of Medicine (IOM)) in 2016, one of the highest honors in the fields of health and medicine. Dr. Califf has served on numerous IOM committees, and he has served as a member of the FDA Cardiorenal Advisory Panel and FDA Science Board's Subcommittee on Science and Technology. Dr. Califf has also served on the Board of Scientific Counselors for the National Library of Medicine, as well as on advisory committees for the National Cancer Institute, the National Heart, Lung, and Blood Institute, the National Institute of Environmental Health Sciences and the Council of the National Institute on Aging.

He has led major initiatives aimed at improving methods and infrastructure for clinical research, including the Clinical Trials Transformation Initiative (CTTI), a public-private partnership co-founded by the FDA and Duke. He also served as the principal investigator for Duke's Clinical and Translational Science Award and the NIH Health Care Systems Research Collaboratory coordinating center and co-PI of the Patient Centered Outcomes Research Institute Network.

Associated Faculty Labs

Publications

Chu, A., R. M. Califf, D. B. Pryor, R. A. McKinnis, F. E. Harrell, K. L. Lee, S. E. Curtis, H. N. Oldham, and G. S. Wagner. “Prognostic effect of bundle branch block related to coronary artery bypass grafting..” Am J Cardiol 59, no. 8 (April 1, 1987): 798–803.

PMID
3493679
Scholars@Duke

Blackshear, J. L., W. G. O’Callaghan, and R. M. Califf. “Medical approaches to prevention of restenosis after coronary angioplasty..” J Am Coll Cardiol 9, no. 4 (April 1987): 834–48.

PMID
2951423
Scholars@Duke

Aldrich, H. R., N. B. Hindman, T. Hinohara, M. G. Jones, J. Boswick, K. L. Lee, W. Bride, R. M. Califf, and G. S. Wagner. “Identification of the optimal electrocardiographic leads for detecting acute epicardial injury in acute myocardial infarction..” Am J Cardiol 59, no. 1 (January 1, 1987): 20–23.

PMID
3812249
Scholars@Duke

Califf, R. M., M. N. Papanicolaou, C. B. McCants, M. A. Hlatky, and D. B. Pryor. “Prognosis in angiographically normal or near-normal coronary arteries.” Cardiology Board Review 4, no. 7 (January 1, 1987): 21–25.

Scholars@Duke

Topol, E. J. “Thrombolysis and angioplasty in myocardial infarction (TAMI) trial.” Journal of the American College of Cardiology 10, no. 5 (January 1, 1987): 65B-74B. https://doi.org/10.1016/S0735-1097(87)80430-8.

Full Text

Pryor, D. B., F. E. Harrell, J. S. Rankin, K. L. Lee, L. H. Muhlbaier, H. Newland Oldham, M. A. Hlatky, D. B. Mark, J. G. Reves, and R. M. Califf. “The changing survival benefits of coronary revascularization over time.” Circulation 76, no. 5 II SUPPL. (January 1, 1987): 13–21.

Scholars@Duke

Mark, D. B., M. A. Hlatky, K. L. Lee, F. E. Harrell, R. M. Califf, and D. B. Pryor. “Localizing coronary artery obstructions with the exercise treadmill test..” Ann Intern Med 106, no. 1 (January 1987): 53–55.

PMID
3789578
Scholars@Duke

Papanicolaou, M. N., R. M. Califf, M. A. Hlatky, R. A. McKinnis, F. E. Harrell, D. B. Mark, B. McCants, R. A. Rosati, K. L. Lee, and D. B. Pryor. “Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries..” Am J Cardiol 58, no. 13 (December 1, 1986): 1181–87.

PMID
3788805
Scholars@Duke

Califf, R. M., D. B. Pryor, and J. C. Greenfield. “Beyond randomized clinical trials: applying clinical experience in the treatment of patients with coronary artery disease..” Circulation 74, no. 6 (December 1986): 1191–94.

PMID
3536148
Scholars@Duke

Hlatky, M. A., T. Haney, J. C. Barefoot, R. M. Califf, D. B. Mark, D. B. Pryor, and R. B. Williams. “Medical, psychological and social correlates of work disability among men with coronary artery disease..” Am J Cardiol 58, no. 10 (November 1, 1986): 911–15.

PMID
3776848
Scholars@Duke

Pages